Choose the language used for shopping and digital communications.
Region
United States (Estados Unidos)
Language
Translation disclaimer: Translations are provided for your convenience. The English Version of OPTAVIA.com, including any and all Legal Notices and Terms and Conditions, is the definitive version.
The GLP-1 Nutrition Support Kit contains high-protein, nutrient-dense foods. It’s designed to help you get fill nutrition gaps that can occur when your appetite is suppressed and retain lean muscle mass as you lose weight.
Create an account with OPTAVIA to get connected with a coach
Personalized support every step of the way
2
Get your tailored nutrition plan
Your OPTAVIA coach will help you choose a customized nutrition plan and, if interested, provide guidance on how to access GLP-1s (if clinically appropriate*) through our collaboration with LifeMD
3
Start your journey and eat better while eating less
Learn lifelong healthy habits with OPTAVIA
Get Started
Reach your goals and support a healthy lifestyle long-term
Get nutrition & lifestyle guidance along with OPTAVIA
and GLP-1 weight loss medication with LifeMD
Your dedicated LifeMD team will explore all options to help you get your GLP-1 medication.
Prescribes GLP-1 medication delivered to your door — to help you lose 15-20% of your body weight.*
Communicate with your insurance
To save you the headache of determining what your insurance will and will not cover, our team will facilitate the communication and completion of paperwork for you.
Explore your medication options
The team will explore medication options that meet your needs. If you get denied for one medication, they'll help find another one that is right for you.
Find solutions to reduce costs
If your insurance doesn't cover the cost of your medication, the team will look for cost lowering programs, or help you explore available cash options.
Get the best price for your GLP-1
LifeMD has a competitive advantage to help patients with the cost of GLP-1 medications, along with discount "coupons" and direct access to other medication options.
Real Stories, Real Successes
"I was surprised mostly how the medication worked so well with what OPTAVIA offers, which is a high protein, low-carb, low glycemic diet. I was pleasantly surprised how smooth the process was to get started with LifeMD."
- Jenny
OPTAVIA client & independent coach
"I chose OPTAVIA's program and weight loss medications because I felt I needed another tool to help me overcome food addictions by suppressing cravings and feeling fuller faster."
- Emily
OPTAVIA client & independent coach
Average weight loss on the Optimal Weight 5 & 1 Plan® is 12 pounds
Still on the fence?
Not ready to commit to GLP-1 medications? Try our plan assigner to discover the OPTAVIA plan that's perfect for you.
*Individual results may vary. 15% body weight loss based on the average weight loss in three 68-week clinical trials of patients on Wegovy without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity. In a 72-week Zepbound (tirzepatide) study of adults without diabetes, average weight loss was 15.0% (34 lbs) for 5 mg, 19.5% (44 lbs) for 10 mg, 20.9% (48 lbs) for 15 mg, and 3.1% (7 lbs) for placebo. In a 72-week Zepbound (tirzepatide) study of adults with diabetes, average weight loss was 12.8% (28 lbs) for 10 mg, 14.7% (33 lbs) for 15 mg, and 3.2% (7 lbs) for placebo. In a 3-year Saxenda study, adults with pre-diabetes and BMI ≥30 or ≥27 with one or more weight-related conditions were given Saxenda or placebo added to a reduced-calorie meal plan and increased physical activity. At year one, 56% of people on Saxenda lost ≥5% of their weight vs 25% of patients on placebo.
**Medical advice, treatment, prescriptions, and the overall practice of medicine must be provided by a licensed healthcare professional. OPTAVIA and its coaches do not engage in or provide any medical services.
¹ Jensterle M, Rizzo M, Haluzík M, Janež A. Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review. Adv Ther. 2022 Jun;39(6):2452-2467. doi: 10.1007/s12325-022-02153-x
² Independent IPSOS research commissioned by OPTAVIA, June 2023